I would also like to clarify that these targets exclude any potential contribution from Enjaymo. Our agreement with Sanofi to acquire the global rights to Enjaymo reaffirms our continuous ...

Recordati Industria Chimica e Farmaceutica SPA (IT:REC) has released an update. Recordati Industria Chimica e Farmaceutica SPA reported strong ...

La Corte also said Recordati would unveil its 2025 outlook in February, along with preliminary 2024 results, taking into account its recent acquisition from Sanofi (SASY.PA), opens new tab of the ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Sanofi has added another string to its Pompe disease therapy bow, after getting FDA approval for Nexviazyme, its latest therapy for the rare, inherited disorder. The US regulator has approved ...

Sanofi has made an interesting choice for its new head of R&D, turning to Houman Ashrafian, who has deep expertise in the biopharma industry, but can also draw on his most recent role as managing ...

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 14,385.85 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...